189 related articles for article (PubMed ID: 32873442)
1. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82-104: Importance of Standardized Pathology Reporting for Urological Cancers in the Implementation of Urology Guidelines.
Paner GP; Montironi R
Eur Urol; 2021 Jan; 79(1):e30-e32. PubMed ID: 32873442
[No Abstract] [Full Text] [Related]
2. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2020;79:82-104.
Baldauf A; Koch R; Heberling U; Thomas C; Froehner M
Eur Urol; 2021 Jan; 79(1):e29. PubMed ID: 32819787
[No Abstract] [Full Text] [Related]
3. Re: J. Alfred Witjes, Thierry Lebret, Eva M. Compérat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017;71:462-75.
Bokarica P; Hrkac A; Gilja I
Eur Urol; 2017 Aug; 72(2):e45. PubMed ID: 28279514
[No Abstract] [Full Text] [Related]
4. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Vetterlein MW; Gild P; Fisch M; Rink M
Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
[No Abstract] [Full Text] [Related]
5. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65.
Sun L; Feng Y
Eur Urol; 2020 Jan; 77(1):e10-e11. PubMed ID: 31607395
[No Abstract] [Full Text] [Related]
6. Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16.
Montorsi F; Moschini M; Briganti A
Eur Urol Oncol; 2023 Jun; 6(3):354. PubMed ID: 37031078
[No Abstract] [Full Text] [Related]
7. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65.
Montorsi F; Bandini M; Necchi A
Eur Urol; 2020 Aug; 78(2):e75-e76. PubMed ID: 32362494
[No Abstract] [Full Text] [Related]
8. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
Vetterlein MW; Rink M
Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
[No Abstract] [Full Text] [Related]
9. Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol 2020;78:489-91: Can Open and Robotic Radical Cystectomy be Considered Equally Effective in 2020?
Witjes JA; Ribal MJ; van der Heijden AG
Eur Urol; 2020 Oct; 78(4):492-493. PubMed ID: 32693931
[No Abstract] [Full Text] [Related]
10. Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182-91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis.
Cimadamore A; Lopez-Beltran A; Scarpelli M; Cheng L; Montironi R
Eur Urol Oncol; 2021 Aug; 4(4):671-673. PubMed ID: 34144939
[No Abstract] [Full Text] [Related]
11. Re: Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017.
Liedberg F; Trägårdh E
Eur Urol; 2023 Mar; 83(3):e82-e83. PubMed ID: 36503644
[No Abstract] [Full Text] [Related]
12. Re: Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol 2018;74:4-7.
Bertolo R
Eur Urol; 2018 Nov; 74(5):e114-e115. PubMed ID: 30017398
[No Abstract] [Full Text] [Related]
13. Reply to Riccardo Bertolo's Letter to the Editor re: Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol 2018;74:4-7.
Gandaglia G; Fossati N; Montorsi F; Briganti A
Eur Urol; 2018 Nov; 74(5):e116-e117. PubMed ID: 30007820
[No Abstract] [Full Text] [Related]
14. Reply to Arnulf Stenzl, Morgan Rouprêt, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193-4.
Heer R; Tan WS; Gravestock P; Vadiveloo T; Lewis R; Penegar S; Vale L; MacLennan G; Hall E;
Eur Urol; 2024 Mar; 85(3):309-312. PubMed ID: 37330372
[No Abstract] [Full Text] [Related]
15. Re: Sven van den Bosch, J. Alfred Witjes. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011;60:493-500.
Banerjee S; Kumar V
Eur Urol; 2012 Mar; 61(3):e13. PubMed ID: 22206799
[No Abstract] [Full Text] [Related]
16. Re: Stavros Gravas, Mauro Gacci, Christian Gratzke, et al. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2023;84:207-22.
Montorsi F; Capogrosso P; Dehò F; Salonia A
Eur Urol; 2023 Dec; 84(6):e142. PubMed ID: 37696741
[No Abstract] [Full Text] [Related]
17. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
[No Abstract] [Full Text] [Related]
18. Re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445-46.
Falkenbach F; Sanguedolce F; Budäus L
Eur Urol; 2023 Dec; 84(6):e149-e150. PubMed ID: 37833175
[No Abstract] [Full Text] [Related]
19. Re: Richard T. Bryan, Wenyu Liu, Sarah J. Pirrie, et al. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study. Eur Urol 2021;80:12-5.
Hu H
Eur Urol; 2021 Sep; 80(3):e85. PubMed ID: 34215485
[No Abstract] [Full Text] [Related]
20. Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77.
Maffezzini M
Eur Urol; 2006 Sep; 50(3):623-4; author reply 624-5. PubMed ID: 16707208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
